Bionano Genomics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Bionano Genomics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 30% to $36,116,000. Profit margin reached -644%. Total operating expenses were $224,811,000.

Profit Margin

Bionano Genomics, Inc. (NASDAQ:BNGO): Profit margin
2016 6.79M -18.84M -277.48%
2017 9.50M -23.36M -245.82%
2018 12.00M -18.49M -154.13%
2019 10.12M -29.83M -294.55%
2020 8.50M -41.13M -483.78%
2021 17.98M -72.43M -402.84%
2022 27.80M -132.59M -476.93%
2023 36.11M -232.49M -643.74%

BNGO Income Statement (2016 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016
Revenue
Revenue
36.11M27.80M17.98M8.50M10.12M12.00M9.50M6.79M
Cost of revenue
26.55M21.85M14.10M5.73M6.76M8.71M6.03M3.57M
Gross profit
9.56M5.94M3.87M2.77M3.36M3.28M3.47M3.21M
Operating exp.
Research and development
54.03M49.04M22.48M10.25M9.08M9.48M12.00M11.43M
Selling and marketing
00000000
Total operating expenses
224.81M137.64M80.97M41.32M29.23M23.70M26.08M24.38M
Operating income
-215.24M-131.69M-77.10M-38.55M-25.87M-20.41M-23.21M-21.16M
Other income (expenses), net
-17.18M986K-1.05M-2.52M-3.94M3.31M-128.00K2.80M
Income before tax
-232.43M-130.71M-78.15M-41.10M-29.81M-18.48M-23.34M-18.83M
Income tax expense
62K1.88M-5.71M29.19K21.04K15.51K18.55K12.92K
Net income
-232.49M-132.59M-72.43M-41.13M-29.83M-18.49M-23.36M-18.84M
Earnings per share
Basic EPS
-6.81-4.58-2.62-3.95-19.92-26.14-86.5-36.06
Diluted EPS
-6.81-4.58-2.62-3.95-19.92-26.14-86.5-36.06
Data sourceData sourceData sourceData sourceData sourceData source